A Phase 1,Randomized, Double--Blind, Placebo-Controlled Study Assessing the Safety and Tolerability, the Pharmacodynamics and Pharmacokinetics of Single-Ascending and Repeated Doses of Inhaled TPI 1100 in Healthy Subjects.

Trial Profile

A Phase 1,Randomized, Double--Blind, Placebo-Controlled Study Assessing the Safety and Tolerability, the Pharmacodynamics and Pharmacokinetics of Single-Ascending and Repeated Doses of Inhaled TPI 1100 in Healthy Subjects.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2012

At a glance

  • Drugs TPI 1100 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Mar 2011 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 18 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top